Apprendre à traduire à partir d'exemples de traductions humaines.
De: Traduction automatique
Suggérer une meilleure traduction
Qualité :
Réalisées par des traducteurs professionnels, des entreprises, des pages web ou traductions disponibles gratuitement.
pharmaceutical group: gonadotrophin-releasing hormone.
flokkun eftir verkun: gónadótrópínleysandi hormón.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
cetrorelix is a luteinising hormone releasing hormone (lhrh) antagonist.
cetrórelix hefur gagnverkandi áhrif gegn losunarhormóni gulbúsmyndandi hormóns (lhrh).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
hypersensitivity to gonadotrophin-releasing hormone (gnrh) or any other gnrh analogue.
ofnæmi fyrir gónadótrópín leysihormóni(gnrh) eða einhverri annarri gnhr-hliðstæðu.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
azagly-nafarelin is a synthetic analogue of gonadotrophin-releasing hormone (gnrh).
azaglý-nafarelín er samtengd hliðstæða gónadótrópínleysandi hormóns (gnrh).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
cetrotide blocks a natural hormone in your body called lhrh (‘luteinising hormone releasing hormone’).
cetrotide kemur í veg fyrir framleiðslu náttúrulegs hormóns í líkama þínum, sem kallast losunarhormón gulbúsmyndandi hormóns (lhrh)
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
medical castration with luteinising hormone releasing hormone (lhrh) analogue should be continued during treatment in patients not surgically castrated.
eistnabælingu með leysihormóni gulbúshormóns (luteinising hormone-releasing hormone, lhrh) hliðstæðum á að halda áfram meðan á meðferð stendur hjá sjúklingum þegar eistnabæling hefur ekki verið gerð með skurðaðgerð.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated for treatment of adult male patients with advanced hormone-dependent prostate cancer.
firmagon er blokki á gónadótrópín-leysihormón (gnrh), ætlað til meðferðar fyrir fullorðna karlmenn með langt gengið hormónaháð blöðruhálskirtilskrabbamein.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
the active substance ganirelix (inn) is a synthetic decapeptide with high antagonistic activity to the naturally occurring gonadotrophin releasing hormone (gnrh).
virka efnið ganirelix (inn) er samtengt dekapeptíð sem hefur mikla hamlandi verkun gegn hinu náttúrulega gónadótrópín leysihormóni (gnrh).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
in study 2, the reduction in menstrual blood loss was comparable for the patients treated with ulipristal acetate and the gonadotrophin releasing hormone-agonist (leuprorelin).
Í rannsókn 2 var minnkun á blóðmissi við tíðablæðingar sambærileg hjá sjúklingum sem fengu meðferð með úlipristal asetati og með örva loshormóns gónadótrópíns (leuprorelin).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
pharmacotherapeutic group: anti-gonadotropin-releasing hormones, atc code: h01cc02.
flokkun eftir verkun: and-gónadótrópínleysandi hormón, atc-flokkur: h01cc02.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
hypersensitivity to the active substance or any structural analogues of gonadotropin-releasing hormone (gnrh), extrinsic peptide hormones or to any of the excipients listed in section 6.1.
ofnæmi fyrir virka efninu eða efnum skyldum gónadótrópínleysandi hormóni (gnrh), utanaðkomandi peptíðhormónum eða einhverju hjálparefnanna sem talin eru upp í kafla 6.1.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
down-regulation with a gonadotropin-releasing hormone (gnrh) agonist or antagonist is now commonly used in order to suppress the endogenous lh surge and to control tonic levels of lh.
stýrð fækkun (down-regulation) er nú algengt að nota, örva (agonist) eða blokka (antagonist) gónadótrópín-losunarhormóns (gnrh), til að hemja innræna (endogenous) lh seytingu (surge) og til að stjórna styrk (tonic levels) lh.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
cetrotide belongs to a group of medicines called ‘anti-gonadotropin-releasing hormones’.
cetrotide tilheyrir hópi lyfja sem hindra myndun gónadótrópínleysandi hormóna.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
during the treatment period, 83% of patients received luteinising hormone-releasing hormone (lhrh) agonists and 26% of patients received anti-androgens concomitantly.
meðan á meðferð stóð fengu 83% sjúklinga leysiþáttar gulbúskveikju örva (lhrh örva) og 26% sjúklinga fengu samhliða andkarlhormón.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
orgalutran contains the active substance ganirelix and belongs to a group of medicines called “anti- gonadotrophin-releasing hormones” which act against the actions of the natural gonadotrophin releasing hormone (gnrh).
orgalutran inniheldur virka efnið ganirelix og er í flokki lyfja sem hindra myndun gónadótrópínleysandi hormóna og verka á móti náttúrulega gónadótrópín leysihormóninu (gnrh).
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
elonva is indicated for controlled ovarian stimulation (cos) in combination with a gonadotropin releasing hormone (gnrh) antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program.
elonva er ætlað til stýrðrar örvunar eggjastokka ásamt gnrh (gonadotropin releasing hormone) hemli til þess að þroska mörg eggbú hjá konum sem gangast undir tæknifrjóvgun.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :
degarelix is a selective gonadotrophin releasing-hormone (gnrh) antagonist that competitively and reversibly binds to the pituitary gnrh receptors, thereby rapidly reducing the release of the gonadotrophins, luteinizing hormone (lh) and follicle stimulating hormone (fsh), and thereby reducing the secretion of testosterone (t) by the testes.
degarelix er sértækur samkeppnisblokki á gónadótrópín-leysihormón (gnrh) sem binst afturkræfri bindingu við gnrh viðtaka í heiladingli og dregur þannig hratt úr losun gónadótrópína, gulbúsörvandi hormóns (lh) og eggbúsörvandi hormóns (fsh) og dregur þar með úr seytrun testósteróns (t) í eistum.
Dernière mise à jour : 2017-04-26
Fréquence d'utilisation : 1
Qualité :